Bristol Myers Squibb (NYSE:BMY) Stock Rating Lowered by Wall Street Zen
Bristol Myers Squibb (NYSE:BMY – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Saturday. Several other research analysts also recently commented on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Bristol […]
13 Apr 01:43 · The Cerbat Gem